Recent preclinical evidence, showing that blocking V600E BRAF expression promotes apoptosis in human melanoma cells, provided a rationale for targeting signalling through RAF/MEK/ERK in the treatment of melanoma (Hingorani et al, 2003; Karasarides et al, 2004). This evidence concerns the gene RAF1 and melanoma.